These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
3. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246 [TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334 [TBL] [Abstract][Full Text] [Related]
5. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
6. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762 [TBL] [Abstract][Full Text] [Related]
7. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618 [TBL] [Abstract][Full Text] [Related]
10. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142 [TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC; Banner B; Glickman J; Odze RD Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors. Zhang C; Schmidt LA; Hatanaka K; Thomas D; Lagstein A; Myers JL Am J Clin Pathol; 2014 Sep; 142(3):320-4. PubMed ID: 25125621 [TBL] [Abstract][Full Text] [Related]
13. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881 [TBL] [Abstract][Full Text] [Related]
14. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. Cho NH; Koh ES; Lee DW; Kim H; Choi YP; Cho SH; Kim DS J Proteome Res; 2006 Mar; 5(3):643-50. PubMed ID: 16512680 [TBL] [Abstract][Full Text] [Related]
15. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Zamecnik J; Kodet R Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814 [TBL] [Abstract][Full Text] [Related]
16. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Kaufmann O; Dietel M Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482 [TBL] [Abstract][Full Text] [Related]
17. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Chang YL; Lee YC; Liao WY; Wu CT Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379 [TBL] [Abstract][Full Text] [Related]
18. Biology and novel therapeutics for neuroendocrine tumors of the lung. Jafri N; Salgia R J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas. Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987 [TBL] [Abstract][Full Text] [Related]
20. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Jiang SX; Kameya T; Shinada J; Yoshimura H Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]